Suchergebnisse - "Dittrich, Anna-Maria"

PubPharm (10)

1

Effect of CFTR modulator therapy with elexacaftor/tezacaftor/ivacaftor on pulmonary ventilation derived by 3D phase-resolved functional lung MRI in cystic fibrosis patients

enthalten in: European radiology | 2024

von Klimeš, F. | Voskrebenzev, A. | Gutberlet, M. | +8

2

The Anion Channel TMEM16a/Ano1 Modulates CFTR Activity, but Does Not Function as an Apical Anion Channel in Colonic Epithelium from Cystic Fibrosis Patients and Healthy Individuals

enthalten in: International journal of molecular sciences | 2023

von Salari, A. | Xiu, R. | Amiri, M. | +6

3

Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR : A Phase 2 Placebo-controlled Clinical Trial

enthalten in: Annals of the American Thoracic Society | 2023

von Stahl, M. | Roehmel, J. | Eichinger, M. | +14

4

Analysis of CF patient survival confirms STAT3 as a CF-modifying gene with changing impact over time

enthalten in: Human molecular genetics | 2023

von Dunsche, I. | Raddatz, E. | Ismer, H. | +8

ErratumIn: Hum Mol Genet. 2022 Dec 26;:. - PMID 36571178

5

Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012-2021

enthalten in: The European respiratory journal | 2023

von Ringshausen, F. | Sauer-Heilborn, A. | Büttner, T. | +6

6

Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome

enthalten in: Microbiology spectrum | 2022

von Pallenberg, S. | Pust, M. | Rosenboom, I. | +4

7

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles

enthalten in: American journal of respiratory and critical care medicine | 2022

von Graeber, S. | Renz, D. | Stahl, M. | +19

CommentIn: Am J Respir Crit Care Med. 2022 Aug 1;206(3):240-242. - PMID 35579627

8

CFTR modulation with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis assessed by the β-adrenergic sweat rate assay

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022

von Pallenberg, S. | Junge, S. | Ringshausen, F. | +5

9

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles

enthalten in: American journal of respiratory and critical care medicine | 2022

von Graeber, S. | Vitzthum, C. | Pallenberg, S. | +16

CommentIn: Am J Respir Crit Care Med. 2022 Mar 1;205(5):487-489. - PMID 35073504

10

Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test

enthalten in: BMJ open respiratory research | 2020

von Minso, R. | Schulz, A. | Dopfer, C. | +14

1
[1]